These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16283030)

  • 61. Natriuretic Peptide and Clinical Evaluation in the Diagnosis of Heart Failure Hemodynamic Profile: Comparison with Tissue Doppler Echocardiography.
    Almeida Junior GLG; Clausell N; Garcia MI; Esporcatte R; Rangel FOD; Rocha RM; Beck-da-Silva L; Silva FBD; Gorgulho PCC; Xavier SS
    Arq Bras Cardiol; 2018 Mar; 110(3):270-277. PubMed ID: 29694552
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure.
    Johnson W; Omland T; Hall C; Lucas C; Myking OL; Collins C; Pfeffer M; Rouleau JL; Stevenson LW
    J Am Coll Cardiol; 2002 May; 39(10):1623-9. PubMed ID: 12020489
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure.
    Steimle AE; Stevenson LW; Chelimsky-Fallick C; Fonarow GC; Hamilton MA; Moriguchi JD; Kartashov A; Tillisch JH
    Circulation; 1997 Aug; 96(4):1165-72. PubMed ID: 9286945
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
    Cioffi G; Tarantini L; Stefenelli C; Azzetti G; Marco R; Carlucci S; Furlanello F
    J Card Fail; 2006 Oct; 12(8):608-15. PubMed ID: 17045179
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.
    Schwartzenberg S; Redfield MM; From AM; Sorajja P; Nishimura RA; Borlaug BA
    J Am Coll Cardiol; 2012 Jan; 59(5):442-51. PubMed ID: 22281246
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Therapy of advanced heart failure adapted to hemodynamic objectives acquired by invasive hemodynamic monitoring].
    Almeida Júnior GL; Esporcatte R; Rangel FO; Rocha RM; Gouvêa e Silva Gde M; Tura BR; Jorge JK; Drumond LE; Albanesi Filho FM
    Arq Bras Cardiol; 2005 Oct; 85(4):247-53. PubMed ID: 16283030
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Early and medium term results of tailored therapy for heart failure.
    Martins S; Soares RM; do Rosário L; Quininha J; Antunes AM
    Rev Port Cardiol; 2001 Mar; 20(3):261-82. PubMed ID: 11417309
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Similar hemodynamic decongestion with vasodilators and inotropes: systematic review, meta-analysis, and meta-regression of 35 studies on acute heart failure.
    Ishihara S; Gayat E; Sato N; Arrigo M; Laribi S; Legrand M; Placido R; Manivet P; Cohen-Solal A; Abraham WT; Jessup M; Mebazaa A
    Clin Res Cardiol; 2016 Dec; 105(12):971-980. PubMed ID: 27314418
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Hemodynamic guidelines in the treatment of acute myocardial infarction by means of vasodilators].
    Zilcher H
    Acta Med Austriaca Suppl; 1979; 15():1-34. PubMed ID: 161946
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Drug treatment of patients with decompensated heart failure.
    Mills RM; Hobbs RE
    Am J Cardiovasc Drugs; 2001; 1(2):119-25. PubMed ID: 14728041
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Nitrates in heart failure: the hemodynamic effects and clinical implications].
    Faggiano P; Rusconi C; Ghizzoni G
    Cardiology; 1994; 84 Suppl 1():52-63. PubMed ID: 8087825
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Pulmonary artery pressure sensor for ambulatory assessment of ventricular filling pressure in advanced heart failure : What should be considered for the follow-up care?].
    Herrmann E; Ecke A; Fichtlscherer S; Zeiher AM; Assmus B
    Herzschrittmacherther Elektrophysiol; 2018 Dec; 29(4):393-400. PubMed ID: 30306304
    [TBL] [Abstract][Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.